• Definium Therapeutics issued inducement stock options covering 115,600 common shares to six newly hired non-executive employees.
• Grants carry an Aug. 3, 2026 effective date; exercise price set at the closing share price on the grant date.
• Options vest over four years: 25% on the first anniversary, then the remainder in equal monthly installments over three years.
• Awards were made under the company’s 2026 Inducement Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608031601BIZWIRE_USPR_____20260803_BW293561) on August 03, 2026, and is solely responsible for the information contained therein.